Tekla Healthcare Investors Stock Today
| HQH Stock | USD 17.46 0.17 0.96% |
PerformanceInsignificant
| Odds Of DistressAbove Average
|
Tekla Healthcare is trading at 17.46 as of the 26th of February 2025. This is a 0.96 percent down since the beginning of the trading day. The stock's open price was 17.63. Tekla Healthcare has over 56 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Financial Services | IPO Date 5th of January 1988 | Classification Financials |
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. Tekla Healthcare operates under Asset Management classification in the United States and is traded on New York Stock Exchange.. The company has 52.13 M outstanding shares of which 145.11 K shares are currently shorted by investors with about 0.22 days to cover. More on Tekla Healthcare Investors
Moving together with Tekla Stock
Moving against Tekla Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Tekla Stock Highlights
ESG Sustainability
Environment Score | Governance Score | Social Score |
| CEO | Daniel Omstead | ||||
| Business Concentration | Asset Management & Custody Banks, Financial Services, Financials, Capital Markets, Asset Management, Financial Services (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsTekla Healthcare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Tekla Healthcare's financial leverage. It provides some insight into what part of Tekla Healthcare's total assets is financed by creditors.
| |||||
Tekla Healthcare Investors (HQH) is traded on New York Stock Exchange in USA. It is located in 1900 Market Street, Philadelphia, PA, United States, 19103 and employs 13 people. Tekla Healthcare is listed under Asset Management & Custody Banks category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 906.02 M. Tekla Healthcare Inv runs under Capital Markets sector within Financials industry. The entity has 52.13 M outstanding shares of which 145.11 K shares are currently shorted by investors with about 0.22 days to cover.
Tekla Healthcare Investors has about 62 in cash with (65.41 M) of positive cash flow from operations.
Check Tekla Healthcare Probability Of Bankruptcy
Ownership AllocationTekla Healthcare Inv shows a total of 52.13 Million outstanding shares. About 74.52 % of Tekla Healthcare outstanding shares are held by general public with 1.8 (%) owned by insiders and only 23.68 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Tekla Ownership Details
Tekla Healthcare Historical Income Statement
Tekla Stock Against Markets
Tekla Healthcare Corporate Management
| Christopher MBA | Senior Manager | Profile | |
| Dr MS | Portfolio Manager | Profile | |
| Lucinda Stebbins | Independent Trustee | Profile | |
| Jeffrey Bailey | Independent Trustee | Profile | |
| Rakesh Jain | Independent Trustee | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 2.04 | Earnings Share 3.53 | Revenue Per Share | Quarterly Revenue Growth 0.172 |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.